Systemic Antibiotics as an Adjunct in Periodontitis

The systemic antibiotic has a defined and a narrow place in the periodontal therapy, and the clinician who respects its limits uses it well while the clinician who reaches for it routinely erodes both the result and the antibiotic stewardship. The mechanical debridement remains the foundation of ...

The systemic antibiotic has a defined and a narrow place in the periodontal therapy, and the clinician who respects its limits uses it well while the clinician who reaches for it routinely erodes both the result and the antibiotic stewardship. The mechanical debridement remains the foundation of the periodontal treatment, and the adjunct is the addition that serves the specific patient whose infection the instruments alone cannot control. The evidence supports the adjunct in the aggressive and the generalized forms where the deep pockets persist after the debridement, and it argues against the routine use in the chronic and the well-managed case. This article reviews the rationale, the evidence, the regimen, and the stewardship that should govern the decision.

The Rationale for the Adjunct

The microorganisms that drive the periodontitis reside in the biofilm that the instrument can reach only partially, and the species that invade the tissue, including the Porphyromonas gingivalis and the Aggregatibacter actinomycetemcomitans, can persist in the gingival tissue and the tonsillar reservoir beyond the reach of the curette. The systemic agent that distributes through the gingival crevicular fluid can reach those niches, which is the biological rationale for the adjunct. The mechanical therapy must precede the drug, because the antibiotic given before the disruption of the biofilm acts on the community that re-forms and the resistant strains that emerge.

The rationale also explains the choice of the combination. The amoxicillin and the metronidazole cover the facultative and the anaerobic species that dominate the subgingival flora, and the combination has been the regimen studied in the trials that support the adjunct. The single agent, by contrast, leaves the gap that the mixed flora exploits, which is why the combination remains the reference.

The Evidence and the Limits

The systematic reviews have found the adjunct to add the modest but the real benefit to the scaling and the root planing in the deep pocket of the aggressive and the generalized disease, and the effect has been measured as the additional pocket depth reduction and the clinical attachment gain at the sites that the instrument could not fully reach. The benefit shrinks in the chronic periodontitis of the smoker and in the patient with the well-maintained disease, and the reviews warn that the indiscriminate use does not improve the outcome that the good debridement already delivers.

The Agents and the Regimen

The regimen that the trials have studied is the amoxicillin 500 mg and the metronidazole 400 mg, each taken three times daily for the seven days, and the combination is started at the completion of the full-mouth debridement so that the drug acts on the biofilm that has just been disrupted. The dose that the patient completes matters, because the interrupted course selects the resistant strain and wastes the benefit that the full course delivers.

The Indications in Practice

The adjunct is reserved for the patient whose disease is generalized, whose pockets remain deep after the debridement, and whose medical history permits the drug. The young patient with the rapid attachment loss and the generalized form is the candidate that the literature names, and the adjunct should be documented as the considered decision with the rationale that the record supports. The patient who has the chronic disease of the long duration and the good plaque control is served by the mechanical therapy and the maintenance rather than by the drug.

Antibiotic Stewardship

The stewardship is the responsibility that accompanies the prescription, and the clinician who orders the adjunct weighs the benefit against the resistance that the population carries. The antibiotic that is prescribed without the indication adds to the pressure that selects the resistant strain, and the periodontal prescriber shares that pressure with the physician and the whole of the practice. The culture and the sensitivity testing are rarely practical in the periodontal infection, which makes the disciplined indication the only real safeguard.

The stewardship also includes the check of the allergy, the interaction, and the pregnancy status before the drug is released, and the conversation with the patient that explains the reason for the prescription and the importance of the full course.

The Maintenance After the Therapy

The adjunct does not replace the maintenance, and the patient who receives the antibiotic still returns for the supportive therapy at the interval that the risk profile sets. The home routine that keeps the gingival margin clean supports the treatment that the drug and the instrument began. A soft electric brush such as the BrushO cleans the sulcus area at a controlled pressure, and the patient who pairs it with the interdental cleaning gives the treated site the conditions that the healing requires.

Clinical Key Points

- Use the systemic antibiotic as the adjunct and never as the substitute for the debridement.

- Reserve the adjunct for the generalized or the aggressive disease with the persistent deep pockets.

- Follow the debridement with the combination of the amoxicillin and the metronidazole where the drug is indicated.

- Check the allergy, the interaction, and the pregnancy status before the prescription.

- Counsel the patient to complete the course and to keep the maintenance interval.

Conclusion

The systemic antibiotic is a sharp tool in the periodontal practice, and its value depends on the discipline that surrounds it. The clinician who debrides first, selects the patient with care, and respects the stewardship gives the patient the benefit that the evidence supports, while the clinician who prescribes by the habit gives the patient the risk without the reward.